Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. April 2026 12:00 ET | Quelle: Regeneron Pharmaceuticals, Inc.

EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing...
02. April 2026 11:58 ET | Quelle: Research and Markets

Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Radioligand Therapy Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights, including...
02. April 2026 11:55 ET | Quelle: Research and Markets

Global Interventional Oncology Industry Set to Grow by $1.18 Billion During 2026-2030 - AI-Assisted Imaging and Minimally Invasive Procedures Drive Interventional Oncology Expansion

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides a detailed analysis of market...
02. April 2026 11:49 ET | Quelle: Research and Markets

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a...
02. April 2026 11:34 ET | Quelle: Research and Markets

Throat Cancer Market Trends and Breakthroughs Through 2026-2030 & 2035 Driven by Precision Oncology

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Throat Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The throat cancer market has exhibited significant growth...
02. April 2026 11:31 ET | Quelle: Research and Markets

Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Tumor Microenvironment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tumor microenvironment (TME) market has...
02. April 2026 11:30 ET | Quelle: SNS Insider pvt ltd

Test Strip Market Set to Hit USD 22.91 Billion by 2035, Driven by Rising Diabetes Burden – SNS Insider

Austin, United States, April 02, 2026 (GLOBE NEWSWIRE) -- Test Strip Market Size & Growth Analysis: According to SNS Insider, The Test Strip Market size is valued at USD 14.79 Billion in 2025...
02. April 2026 11:01 ET | Quelle: CREDIT AGRICOLE SA

CREDIT AGRICOLE SA : Déclaration des droits de vote mars 2026

Raison sociale de l’émetteur : Crédit Agricole S.A. – SA au capital de 9 077 707 050 eurosImmatriculée sous le n° 784 608 416 R.C.S. NANTERRESiège social : MONTROUGE (92120) 12, place des Etats-Unis...
02. April 2026 11:00 ET | Quelle: SAVENCIA

SAVENCIA : Mise à disposition des documents préparatoires à l'Assemblée Générale

SAVENCIA SA informe ses actionnaires qu’ils sont convoqués en Assemblée Générale Mixte (Ordinaire et Extraordinaire) le 23 avril 2026 à 10 heures 30 au siège social : 42 rue Rieussec – 78220 Viroflay....
02. April 2026 10:50 ET | Quelle: Research and Markets

Next-Gen Oncology Devices and Solutions Market to Double by 2030, Reaching Over $38 Billion

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Next-Generation Oncology Devices and Solutions Market Report 2026" has been added to ResearchAndMarkets.com's offering. The next-generation...

Vorherige Seite

Nächste Seite